Adderall XR faces first generic competition in US
This article was originally published in Scrip
Teva Pharmaceutical Industries has launched its generic version of Shire's Adderall XR (amphetamine mixed salts) capsules in the US, in five strengths. Shire has been saying for some time that it expected an April 1st launch by Teva for the attention deficit hyperactivity disorder (ADHD) product. There is currently no generic competition in the US for the product.